Related Experiment Video
Updated: Jun 14, 2025
A Fast and Reliable Pipeline for Bacterial Transcriptome Analysis Case study: Serine-dependent Gene Regulation in Streptococcus pneumoniae
Published on: April 25, 2015
Utilizing large and diverse bacterial genome datasets to improve the detection and identification of Streptococcus
Femke M Ahlers1, David J Litt2, Melissa J Jansen van Rensburg1
1Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Abstract:
The accurate identification of Streptococcus pneumoniae (pneumococcus) is crucial for diagnostics and surveillance but is complicated by the use of molecular assays that may also detect non-pneumococcal Streptococcus (NPS) species. Therefore, the aim of this study was to use a combination of in silico and in vitro analyses to evaluate PCR assays for the molecular detection and identification of pneumococci. A diverse dataset of over 9,300 pneumococcal and NPS genomes was investigated in silico to determine the sensitivity and specificity of assays for seven recommended gene targets: lytA, piaB, ply, psaA, Spn9802, SP2020 and Xisco. These in silico findings were used to design new diagnostic assays for two targets, Xisco and SP2020. The new assays were evaluated in vitro using three sets of isolates, one of which was selected based upon evidence for sequence diversity from a second in silico investigation of over 6,000 pneumococcal genomes sequenced by the United Kingdom Health Security Agency. Experimentally, the new Xisco and SP2020 assays were compared to published assays for lytA and piaB. The in vitro specificity was 100% (95% CI, 98.7-100%) across all assays. The in vitro sensitivity was 100% (95% CI, 98.5-100%) for lytA, SP2020_new and the Xisco assays and 99.6% (95% CI, 97.8-100%) for piaB. The new assays were found to be highly sensitive and specific and able to detect as few as two pneumococcal genome copies per quantitative PCR reaction. Overall, this study demonstrated the value of performing large-scale in silico genomic analyses of diagnostic targets, followed by in vitro testing that was specifically designed to account for global pneumococcal population-level diversity.
Insights
Accurate identification of Streptococcus pneumoniae (pneumococcus) is vital for disease control. This study developed and validated new PCR assays, Xisco and SP2020, showing high sensitivity and specificity for pneumococcal detection.
Area of Science:
- Microbiology
- Genomics
- Molecular Diagnostics
Background:
- Accurate identification of Streptococcus pneumoniae (pneumococcus) is critical for diagnostics and surveillance.
- Existing molecular assays can misidentify non-pneumococcal Streptococcus (NPS) species, complicating accurate detection.
Purpose of the Study:
- To evaluate existing and develop new PCR assays for the precise molecular detection and identification of pneumococci.
- To assess assay performance using both in silico and in vitro analyses, accounting for genomic diversity.
Main Methods:
- In silico analysis of over 9,300 pneumococcal and NPS genomes to assess seven gene targets (lytA, piaB, ply, psaA, Spn9802, SP2020, Xisco).
- Design and in vitro evaluation of new diagnostic assays for Xisco and SP2020 targets.
- Comparison of new assays against established lytA and piaB assays using diverse bacterial isolates.
Main Results:
- In vitro specificity was 100% for all tested assays.
- In vitro sensitivity reached 100% for lytA, SP2020_new, and Xisco assays, and 99.6% for piaB.
- New Xisco and SP2020 assays demonstrated high sensitivity and specificity, detecting as few as two pneumococcal genome copies.
Conclusions:
- Large-scale in silico genomic analysis is valuable for designing effective diagnostic targets.
- The developed Xisco and SP2020 assays are highly sensitive and specific for pneumococcal detection.
- In vitro validation incorporating population diversity is essential for reliable molecular diagnostic assays.
